Stratos Wealth Partners, Ltd. Anavex Life Sciences Corp. Transaction History

Stratos Wealth Partners, Ltd.

  • $6.79 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024
BUY
$4.55 - $6.75 $49,149 - $72,913
10,802 New
10,802 $54,000
Q2 2021

Jul 19, 2021
SELL
$10.16 - $28.86 $112,776 - $320,346
-11,100 Closed
0 $0
Q1 2021

Apr 27, 2021
BUY
$5.17 - $16.13 $57,387 - $179,043
11,100 New
11,100 $166,000

Others Institutions Holding AVXL

# of Institutions
157
Shares Held
27.4M
Call Options Held
515K
Put Options Held
838K
View Full List

About ANAVEX LIFE SCIENCES CORP.

AVXL Quotes by TradingView
  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $875M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Stratos Wealth Partners, Ltd. Portfolio

Follow Stratos Wealth Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email